Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

90.80
Delayed Data
As of 4:14pm ET
 +0.82 / +0.91%
Today’s Change
71.46
Today|||52-Week Range
103.73
+23.25%
Year-to-Date

Today’s Trading

Previous close89.98
Today’s open89.28
Day’s range88.90 - 91.49
Volume1,383,188
Average volume (3 months)1,731,394
Market cap$22.4B
Dividend yield--
Data as of 4:14pm ET, 03/27/2017

Growth & Valuation

Earnings growth (last year)+80.09%
Earnings growth (this year)+87.33%
Earnings growth (next 5 years)+68.70%
Revenue growth (last year)+64.89%
P/E ratioNM
Price/Sales10.59
Price/Book19.32

Competitors

 Today’s
change
Today’s
% change
MYLMylan NV+0.75+1.83%
ZTSZoetis Inc+0.12+0.22%
ALXNAlexion Pharmaceutic...-0.43-0.36%
BAXBaxter International...-0.19-0.37%
Data as of 4:01pm ET, 03/27/2017

Financials

Next reporting dateMay 3, 2017
EPS forecast (this quarter)$0.31
Annual revenue (last year)$1.7B
Annual profit (last year)-$112.1M
Net profit margin-6.58%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeffrey M. Leiden
EVP, Chief Operating &
Financial Officer
Ian F. Smith
Corporate headquarters
Boston, Massachusetts

Forecasts


Search for Jobs